A Microcap Riding the $200 Billion GLP-1 Gold Rush
While everyone fights over who sells the shovels, this tiny company owns the tollbooth.
To read our full disclaimer, click here.
Picture this: Every online weight-loss clinic, testosterone provider, and peptide company in America needs the same thing - a way to legally prescribe and distribute medications across all 50 states.
The regulatory nightmare is real. Getting licensed takes months. Building doctor networks costs millions. Securing pharmacy partnerships requires scale nobody has.
Unless you use this company's platform.
They've built the only turnkey infrastructure that lets anyone launch a telehealth company in days, not years. Think "Shopify for healthcare" - but with regulatory moats that actually matter.
Now here's where it gets interesting:
Last month, they bought into the pharmacy itself.
Not just access. Ownership.
Which means they're no longer just charging tolls on the bridge - they're buying into the entire supply chain. From doctor consultation to pill delivery.
The timing couldn't be better:
June orders: 7,000-10,000 (met targets)
July projection: 35,000-70,000 orders
Current run rate: 2,000 orders/day
Current margins: High teens
Target margins: 20-30%
The market sees another sketchy Canadian microcap with a confusing business model.
What they're missing: This company is processing 2,000 prescriptions per day, growing 50% annually, and just secured preferential pharmacy pricing that could double their margins.
While Hims burns cash on Super Bowl ads and Ro fights for market share, this company quietly built the infrastructure layer that everyone else needs to exist.